Lv1
60 积分 2025-03-04 加入
Incidence and Mortality of Colorectal Cancer in Asia in 2022 and Projections for 2050
2天前
已完结
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia
22天前
已完结
Incidence of newly recognized atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy treated with Mavacamten
1个月前
已完结
Atrial Fibrillation in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy
1个月前
已完结
Authorship Trends in Nephrology and Urology
1个月前
已完结
Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy
1个月前
已关闭
Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy
1个月前
已关闭
Two cardiac myosin inhibitors in the treatment of obstructive hypertrophic cardiomyopathy
2个月前
已完结
Aficamten—A Second in Class Cardiac Myosin Inhibitor for Hypertrophic Cardiomyopathy
2个月前
已完结
LONG-TERM EFFICACY AND SAFETY OF AFICAMTEN IN PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
2个月前
已关闭
皖公网安备34019202002308
